Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Sep 19, 2017BD Ultra-Fine(TM) Micro 6mm Pen Needles Now AvailableBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the introduction of the BD Ultra-Fine(TM) micro pen needle 6mm x 32G for use with...
Sep 12, 2017BD Rhapsody(TM) single cell analysis system launches for gene expression profiling, plans to expand for protein analysisBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of BD Rhapsody, a platform for single cell analysis with the ability to...
-
Aug 28, 2017
SAN DIEGO, Aug. 28, 2017 - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, Direct Relief and the National Association of Community Health Centers...
-
Aug 14, 2017
FRANKLIN LAKES, N.J., August 14, 2017 – BD (Becton, Dickinson and Company), a leading global medical technology company, has obtained 510(k) clearance from the U.S. Food and Drug Administration...
-
Aug 3, 2017
Click on the links below to view results for 2017 Third Fiscal Quarter: View Document Online PDF File of BD 2017 Third Fiscal Quarter Results About BD BD is one of the largest global medical...